Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2000 1
2003 1
2004 2
2005 3
2006 6
2007 5
2009 2
2010 8
2011 8
2012 7
2013 6
2014 2
2015 3
2016 6
2017 4
2018 1
2019 8
2020 4
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 22815234

74 results
Results by year
Filters applied: . Clear all
Page 1
Cannabidiol in inflammatory bowel diseases: a brief overview.
Esposito G, Filippis DD, Cirillo C, Iuvone T, Capoccia E, Scuderi C, Steardo A, Cuomo R, Steardo L. Esposito G, et al. Phytother Res. 2013 May;27(5):633-6. doi: 10.1002/ptr.4781. Epub 2012 Jul 20. Phytother Res. 2013. PMID: 22815234 Review.
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.
Jamontt JM, Molleman A, Pertwee RG, Parsons ME. Jamontt JM, et al. Br J Pharmacol. 2010 Jun;160(3):712-23. doi: 10.1111/j.1476-5381.2010.00791.x. Br J Pharmacol. 2010. PMID: 20590574 Free PMC article.
Advances in inflammatory bowel diseases in children.
Michail S, Ramsy M, Soliman E. Michail S, et al. Minerva Pediatr. 2012 Jun;64(3):257-70. Minerva Pediatr. 2012. PMID: 22555319 Review.
Cannabis use amongst patients with inflammatory bowel disease.
Lal S, Prasad N, Ryan M, Tangri S, Silverberg MS, Gordon A, Steinhart H. Lal S, et al. Eur J Gastroenterol Hepatol. 2011 Oct;23(10):891-6. doi: 10.1097/MEG.0b013e328349bb4c. Eur J Gastroenterol Hepatol. 2011. PMID: 21795981
The case for assessing cannabidiol in epilepsy.
Cilio MR, Thiele EA, Devinsky O. Cilio MR, et al. Epilepsia. 2014 Jun;55(6):787-90. doi: 10.1111/epi.12635. Epub 2014 May 22. Epilepsia. 2014. PMID: 24854434 Free article.
Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial.
Couch DG, Cook H, Ortori C, Barrett D, Lund JN, O'Sullivan SE. Couch DG, et al. Inflamm Bowel Dis. 2019 May 4;25(6):1006-1018. doi: 10.1093/ibd/izz017. Inflamm Bowel Dis. 2019. PMID: 31054246 Clinical Trial.
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
Scuderi C, Filippis DD, Iuvone T, Blasio A, Steardo A, Esposito G. Scuderi C, et al. Phytother Res. 2009 May;23(5):597-602. doi: 10.1002/ptr.2625. Phytother Res. 2009. PMID: 18844286 Review.
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M. Caprilli R, et al. Dig Liver Dis. 2005 Jun;37(6):407-17. doi: 10.1016/j.dld.2004.12.013. Dig Liver Dis. 2005. PMID: 15893279 Review.
74 results
Jump to page
Feedback